AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2022
May 3, 2022
34105_dirs_2022-05-03_748f27ed-3157-4965-8301-8add0410073f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2022-05-03
Reporting Person: Saeli Thomas Louis (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-03 | Common Stock; $.10 par value | P | 10000 | $4.885 | Acquired | 70446 | Direct |
Footnotes
F1: The price reported is a weighted average price. The shares were purchased in two transactions of 5,000 shares each at $4.87 and $4.90.
More from ULTRALIFE CORP
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 5